Paxlovid is a deadly, dangerous, carcinogenic drug. It's a known trojan horse drug which will cause endless health problems. The makers know so & so does the FDA that just got it an EUA to shove it into people looking for relief from their injection caused damage, will get more. pic.twitter.com/zDwIVnnHrr
— AOENews (@AOECOINnews) December 24, 2021
Paxlovid is sold as an anti-viral that will put the brakes on SARS-CoV-2. Wasn't that what the vaccines were designed to do? It is manufactured by Pfizer which has a disastrous track record on health. I wouldn't trust them to make laundry detergent. If you hear this name, tell your doctor or nurse or whomever is offering it to you to go away. It's prescribed under other names as well, so be vigilant: Nirmatrelvir and Ritonavir. I resent how Pfizer's marketing inserts "lov" in its name in an effort to make it sound like a trusted form of relief. It's not trusted, like most of Pfizer products. Read the excerpt below. For now, read this:
[It] is an investigational SARS-CoV-2 protease inhibitor antiviral co-packaged with ritonavir authorized for emergency use for the treatment of high-risk patients with COVID-19 to prevent severe illness which can lead to hospitalization and death.
It's deceptive. If you think they're being transparent, talk to all the folks who took their vaccine and developed blood clots throughout their bodies. Don't fall for it. Step away from this drug. Focus on the burning sensations of the "t's" and the "v's" and the "r's" in those two names. Don't get burned.
Paxlovid (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is an investigational SARS-CoV-2 protease inhibitor antiviral co-packaged with ritonavir authorized for emergency use for the treatment of high-risk patients with COVID-19 to prevent severe illness which can lead to hospitalization and death.
Paxlovid contains the novel antiviral nirmatrelvir (PF-07321332) which works by blocking the activity of SARS-CoV-2 main protease (Mpro), also known as SARS-CoV2 3CL protease, an enzyme that the coronavirus that causes COVID-19 needs to replicate. Co-administration with low dose ritonavir helps slow the metabolism of nirmatrelvir allowing it to remain active in the body for longer periods of time at higher concentrations to help combat the virus.
